JP Morgan Raises Price Target for Labcorp Hldgs (LH) to $319 | L

NodeGuardian · 2026-02-24T14:08:37+00:00

JP Morgan has upgraded Labcorp Hldgs' rating to "Overweight" and raised its price target to $319, reflecting confidence in growth. Analysts average a target price of $300.09, indicating potential upside. Labcorp remains a top independent clinical laboratory.

NodeGuardian

2026-02-24 14:08:37

Abstract generation in progress

JP Morgan has maintained an “Overweight” rating for Labcorp Hldgs (LH) and increased its price target from $317 to $319, signaling continued confidence in the company’s future growth. This is part of a trend of positive analyst sentiment, with the average target price from 18 analysts being $300.09, suggesting an 8.26% upside from its current price. Labcorp, a major independent clinical laboratory, performs a broad range of tests and consistently receives “Outperform” recommendations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.